Back to Report Store Home

Transplant Complications Drug Development Pipeline Review, 2018

  • Published: Nov-2018
  • Report Code: GBIHC051IDB
  • Report Format: pdf

Description

List of Figures

Figure 1: Number of Products under Development for Graft Versus Host Disease (GVHD)

Figure 2: Number of Products under Development by Companies, Graft Versus Host Disease (GVHD)

Figure 3: Number of Products under Development by Universities/Institutes, Graft Versus Host Disease (GVHD)

Figure 4: Number of Products under Development for Liver Transplant Rejection

Figure 5: Number of Products under Development by Companies, Liver Transplant Rejection

Figure 6: Number of Products under Development by Universities/Institutes, Liver Transplant Rejection

Figure 7: Number of Products under Development for Kidney Transplant Rejection

Figure 8: Number of Products under Development by Companies, Kidney Transplant Rejection

Figure 9: Number of Products under Development by Universities/Institutes, Kidney Transplant Rejection

Figure 10: Number of Products under Development for Lung Transplant Rejection

Figure 11: Number of Products under Development by Companies, Lung Transplant Rejection

Figure 12: Number of Products by Top 10 Targets, Graft Versus Host Disease (GVHD)

Figure 13: Number of Products by Stage and Top 10 Targets, Graft Versus Host Disease (GVHD)

Figure 14: Number of Products by Top 10 Mechanism of Actions, Graft Versus Host Disease (GVHD)

Figure 15: Number of Products by Stage and Top 10 Mechanism of Actions, Graft Versus Host Disease (GVHD)

Figure 16: Number of Products by Routes of Administration, Graft Versus Host Disease (GVHD)

Figure 17: Number of Products by Stage and Routes of Administration, Graft Versus Host Disease (GVHD)

Figure 18: Number of Products by Top 10 Molecule Types, Graft Versus Host Disease (GVHD)

Figure 19: Number of Products by Stage and Top 10 Molecule Types, Graft Versus Host Disease (GVHD)

Figure 20: Number of Products by Top 10 Targets, Liver Transplant Rejection

Figure 21: Number of Products by Stage and Top 10 Targets, Liver Transplant Rejection

Figure 22: Number of Products by Top 10 Mechanism of Actions, Liver Transplant Rejection

Figure 23: Number of Products by Stage and Top 10 Mechanism of Actions, Liver Transplant Rejection

Figure 24: Number of Products by Routes of Administration, Liver Transplant Rejection

Figure 25: Number of Products by Stage and Routes of Administration, Liver Transplant Rejection

Figure 26: Number of Products by Molecule Types, Liver Transplant Rejection

Figure 27: Number of Products by Stage and Molecule Types, Liver Transplant Rejection

Figure 28: Number of Products by Top 10 Targets, Kidney Transplant Rejection

Figure 29: Number of Products by Stage and Top 10 Targets, Kidney Transplant Rejection

Figure 30: Number of Products by Top 10 Mechanism of Actions, Kidney Transplant Rejection

Figure 31: Number of Products by Stage and Top 10 Mechanism of Actions, Kidney Transplant Rejection

Figure 32: Number of Products by Routes of Administration, Kidney Transplant Rejection

Figure 33: Number of Products by Stage and Routes of Administration, Kidney Transplant Rejection

Figure 34: Number of Products by Top 10 Molecule Types, Kidney Transplant Rejection

Figure 35: Number of Products by Stage and Top 10 Molecule Types, Kidney Transplant Rejection

Figure 36: Number of Products by Targets, Lung Transplant Rejection

Figure 37: Number of Products by Stage and Targets, Lung Transplant Rejection

Figure 38: Number of Products by Mechanism of Actions, Lung Transplant Rejection

Figure 39: Number of Products by Stage and Mechanism of Actions, Lung Transplant Rejection

Figure 40: Number of Products by Routes of Administration, Lung Transplant Rejection

Figure 41: Number of Products by Stage and Routes of Administration, Lung Transplant Rejection

Figure 42: Number of Products by Molecule Types, Lung Transplant Rejection

Figure 43: Number of Products by Stage and Molecule Types, Lung Transplant Rejection

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$11985
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards